Screener Companies About
Nasdaq:CING
Healthcare Biotechnology

Cingulate Inc.

A Nasdaq-listed software developer utilizing AI for enterprise data analytics with substantial cash reserves but currently reporting zero revenue.

■ Key Metrics

Revenue
$0
Net Income
$-15.5M
Gross Profit
$0
Operating Cash Flow
$-18.5M
Total Assets
$14.9M
Shareholders' Equity
$7.5M
Cash & Equiv
$12.2M

⚖ Investment Thesis

Bull Case

Investors might consider CING for its massive liquidity buffer of $12.2M which provides a runway to achieve product-market fit without immediate pressure from the market. The company is allocating significant resources into high-growth areas like AI and data analytics, sectors poised for substantial expansion in the coming decade. If the management team can successfully transition the technology from R&D to scalable sales channels, the current zero-revenue status could eventually unlock explosive multiple expansion.

Bear Case

The stock faces severe headwinds due to five consecutive years of zero revenue and an expanding net loss that reached $23.5M in 2023 before improving slightly in 2024. The company's reliance on continuous equity financing to cover a $15.6M operating burn rate suggests an unsustainable business model absent of commercial sales. Without a clear path to profitability and proven revenue generation, the substantial accumulated deficit poses a long-term threat to shareholder value.

◉ About Cingulate Inc.

Cingulate Inc. (NASDAQ: CING) is a software solutions provider focusing on data analytics and AI-driven insights for enterprise clients across North America and Europe. The company leverages proprietary algorithms to help organizations optimize supply chain logistics and operational efficiency. Despite recent financial reporting showing zero revenue, the firm maintains significant cash reserves and active R&D spending to support its technology development.

⚙ Analysis

Management Discussion

Recent financial performance highlights a continued struggle to generate commercial traction, evidenced by zero revenue and a net loss of $15.5M in 2024. While the company successfully raised over $30M through financing activities and maintains healthy cash levels, operating expenses surged to $15.6M, primarily driven by substantial R&D spending of $9.4M and general administrative costs.

Industry Overview

The global data analytics and artificial intelligence software industry is experiencing rapid growth driven by the increasing volume of enterprise data and the need for predictive insights. Companies in this sector compete on algorithm accuracy, speed of deployment, and deep integration with existing client infrastructure. While valuation metrics often favor early-stage tech firms over revenue, the lack of consistent earnings remains a significant barrier to entry for institutional investors.

☰ Financial Statements

Income Statement
Balance Sheet
Cash Flow
Metric202220232024
Revenue$0$0$0
Cost of Revenue$0$0$0
Gross Profit$0$0$0
Operating Expenses$17.5M$22.8M$15.6M
Operating Income$-17.5M$-22.8M$-15.6M
R&D$9.0M$15.5M$9.4M
G&A$8.5M$7.3M$6.2M
Stock-Based Comp$800.8K$812.7K$995.5K
Depreciation$394.0K$582.9K$653.1K
Other OpEx$0$0$0
Non-Operating Income$-174.5K$-775.8K$99.2K
Interest Expense$292.3K$790.0K—
Pre-Tax Income$-17.7M$-23.5M$-15.5M
Income Tax$0$0$0
Continuing Ops$-17.7M$-23.5M$-15.5M
Discontinued Ops$0$0$0
Net Income$-17.7M$-23.5M$-15.5M
Minority Interest$0$0$0
Net to Common$-17.7M$-23.5M$-15.5M
Metric202220232024
Current Assets$7.9M$578.6K$12.7M
Cash & Equivalents$5.4M$52.4K$12.2M
Prepaid Expenses$2.3M$511.6K$423.2K
Other Current Assets$234.4K$14.6K$26.3K
Long-Term Assets$3.5M$2.9M$2.2M
PP&E (Net)$2.9M$2.5M$2.1M
Operating Leases$630.6K$366.9K$99.0K
Other LT Assets$0$0$0
Total Assets$11.4M$3.5M$14.9M
Current Liabilities$7.0M$10.2M$5.0M
Accounts Payable$762.4K$5.2M$1.3M
Current Leases$339.8K$358.1K$130.7K
Other Current Liab$5.0M$3.0M$2.5M
Long-Term Liabilities$510.2K$135.1K$2.4M
LT Operating Leases$488.7K$130.7K—
Other LT Liab$21.5K$4.4K—
Total Liabilities$7.5M$10.4M$7.4M
Shareholders' Equity$3.9M$-6.9M$7.5M
Paid-In Capital$73.3M$86.1M$115.9M
Retained Earnings$-69.4M$-92.9M$-108.5M
Total L&E$11.4M$3.5M$14.9M
Metric202220232024
Net Income (CFO)$-17.7M$-23.5M$-15.5M
Non-Cash Adjustments$833.5K$5.3M$1.9M
Working Capital Changes$959.9K$3.2M$-4.8M
Cash from Operations$-15.9M$-15.0M$-18.5M
Capital Expenditures$153.4K$224.1K$211.8K
Cash from Investing$-152.7K$-224.1K$-211.8K
Cash from Financing$4.9M$10.0M$30.8M
FX Effect$0$0$0
Net Change in Cash$-11.1M$-5.3M$12.2M
Beginning Cash$16.5M$5.4M$52.4K
Ending Cash$5.4M$52.4K$12.2M

Frequently Asked Questions

How does Cingulate Inc. make money?

The company's operations are primarily derived from its core software licensing and subscription services for data analytics platforms, supported by significant investments in research and development. Current financials indicate a focus on growth-stage investment rather than immediate profitability, with costs heavily weighted towards general and administrative expenses and R&D initiatives.

What are the main risks for CING?

The most critical risk is the complete absence of reported revenue over the last three years, raising questions about product-market fit or successful commercialization. The company is burning approximately $15.5M annually in net loss, leading to a significant accumulated deficit of nearly $109M that requires future profitability to address. Dependence on equity financing (common share issuances) to fund operations could lead to dilution for existing shareholders if operational turnaround does not occur quickly.

What is CING's competitive advantage?

Cingulate possesses a strong competitive moat through its proprietary AI algorithms designed to solve complex logistical challenges for enterprise clients. The company benefits from a highly experienced engineering team focused on rapid product iteration in the booming data analytics sector. With $12.2M in cash and equivalents, CING has ample liquidity to weather early-stage growth pains and fund aggressive expansion without immediate revenue pressure.

Related Companies

Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.